Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s)
Autor(a) principal: | |
---|---|
Data de Publicação: | 2015 |
Outros Autores: | , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNESP |
Texto Completo: | http://www.hindawi.com/journals/ecam/2015/678218/ http://hdl.handle.net/11449/129364 |
Resumo: | This study measures the curcumin concentration in rat plasma by liquid chromatography and investigates the changes in the glucose tolerance and insulin sensitivity of streptozotocin-diabetic rats treated with curcumin-enriched yoghurt. The analytical method for curcumin detection was linear from 10 to 500 ng/mL. The C-max and the time to reach C-max (t(max)) of curcumin in plasma were 3.14 perpendicular to 0.9 mu g/mL and 5 minutes (10 mg/kg, i.v.) and 0.06 perpendicular to 0.01 mu g/mL and 14 minutes (500 mg/kg, p.o.). The elimination half-time was 8.64 +/- 2.31 (i.v.) and 32.70 +/- 12.92 (p.o.) minutes. The oral bioavailability was about 0.47%. Changes in the glucose tolerance and insulin sensitivity were investigated in four groups: normal and diabetic rats treated with yoghurt (NYOG and DYOG, resp.) and treated with 90 mg/kg/day curcumin incorporated in yoghurt (NC90 and DC90, resp.). After 15 days of treatment, the glucose tolerance and the insulin sensitivity were significantly improved in DC90 rats in comparison with DYOG, which can be associated with an increase in the AKT phosphorylation levels and GLUT4 translocation in skeletal muscles. These findings can explain, at least in part, the benefits of curcumin-enriched yoghurt to diabetes and substantiate evidences for the curcumin metabolite(s) as being responsible for the antidiabetic activity. |
id |
UNSP_03ac1042876fb956b04e78d772c2ee3a |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/129364 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s)This study measures the curcumin concentration in rat plasma by liquid chromatography and investigates the changes in the glucose tolerance and insulin sensitivity of streptozotocin-diabetic rats treated with curcumin-enriched yoghurt. The analytical method for curcumin detection was linear from 10 to 500 ng/mL. The C-max and the time to reach C-max (t(max)) of curcumin in plasma were 3.14 perpendicular to 0.9 mu g/mL and 5 minutes (10 mg/kg, i.v.) and 0.06 perpendicular to 0.01 mu g/mL and 14 minutes (500 mg/kg, p.o.). The elimination half-time was 8.64 +/- 2.31 (i.v.) and 32.70 +/- 12.92 (p.o.) minutes. The oral bioavailability was about 0.47%. Changes in the glucose tolerance and insulin sensitivity were investigated in four groups: normal and diabetic rats treated with yoghurt (NYOG and DYOG, resp.) and treated with 90 mg/kg/day curcumin incorporated in yoghurt (NC90 and DC90, resp.). After 15 days of treatment, the glucose tolerance and the insulin sensitivity were significantly improved in DC90 rats in comparison with DYOG, which can be associated with an increase in the AKT phosphorylation levels and GLUT4 translocation in skeletal muscles. These findings can explain, at least in part, the benefits of curcumin-enriched yoghurt to diabetes and substantiate evidences for the curcumin metabolite(s) as being responsible for the antidiabetic activity.Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Faculdade de Ciencias Farmaceuticas (FCFAr-UNESP)Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Department of Biochemistry and Immunology, School of Medicine, University of São Paulo (USP), Avenida Bandeirantes 3900, 14040-900 Ribeirão Preto, SP, BrazilDepartment of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Rodovia Araraquara-Jaú Km 01, 14801-902 Araraquara, SP, BrazilDepartment of Natural Active Principles and Toxicology, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Rodovia Araraquara-Jaú Km 01, 14801-902 Araraquara, SP, BrazilHindawi Publishing CorporationUniversidade Estadual Paulista (Unesp)Universidade de São Paulo (USP)Gutierres, Vania Ortega [UNESP]Campos, Michel Leandro [UNESP]Arcaro, Carlos Alberto [UNESP]Assis, Renata Pires [UNESP]Baldan-Cimatti, Helen Mariana [UNESP]Peccinini, Rosangela Gonçalves [UNESP]Paula-Gomes, SilviaKettelhut, Isis CarmoBaviera, Amanda Martins [UNESP]Brunetti, Iguatemy Lourenço [UNESP]2015-10-21T20:55:59Z2015-10-21T20:55:59Z2015-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1-13application/pdfhttp://www.hindawi.com/journals/ecam/2015/678218/Evidence-based Complementary And Alternative Medicine. New York: Hindawi Publishing Corporation, p. 1-13, 2015.1741-427Xhttp://hdl.handle.net/11449/12936410.1155/2015/678218WOS:000355808600001WOS000355808600001.pdf10667434239290933736475025187750Web of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengEvidence-based Complementary And Alternative Medicine2.064info:eu-repo/semantics/openAccess2024-06-24T14:52:03Zoai:repositorio.unesp.br:11449/129364Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T23:57:02.217727Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s) |
title |
Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s) |
spellingShingle |
Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s) Gutierres, Vania Ortega [UNESP] |
title_short |
Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s) |
title_full |
Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s) |
title_fullStr |
Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s) |
title_full_unstemmed |
Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s) |
title_sort |
Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s) |
author |
Gutierres, Vania Ortega [UNESP] |
author_facet |
Gutierres, Vania Ortega [UNESP] Campos, Michel Leandro [UNESP] Arcaro, Carlos Alberto [UNESP] Assis, Renata Pires [UNESP] Baldan-Cimatti, Helen Mariana [UNESP] Peccinini, Rosangela Gonçalves [UNESP] Paula-Gomes, Silvia Kettelhut, Isis Carmo Baviera, Amanda Martins [UNESP] Brunetti, Iguatemy Lourenço [UNESP] |
author_role |
author |
author2 |
Campos, Michel Leandro [UNESP] Arcaro, Carlos Alberto [UNESP] Assis, Renata Pires [UNESP] Baldan-Cimatti, Helen Mariana [UNESP] Peccinini, Rosangela Gonçalves [UNESP] Paula-Gomes, Silvia Kettelhut, Isis Carmo Baviera, Amanda Martins [UNESP] Brunetti, Iguatemy Lourenço [UNESP] |
author2_role |
author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Estadual Paulista (Unesp) Universidade de São Paulo (USP) |
dc.contributor.author.fl_str_mv |
Gutierres, Vania Ortega [UNESP] Campos, Michel Leandro [UNESP] Arcaro, Carlos Alberto [UNESP] Assis, Renata Pires [UNESP] Baldan-Cimatti, Helen Mariana [UNESP] Peccinini, Rosangela Gonçalves [UNESP] Paula-Gomes, Silvia Kettelhut, Isis Carmo Baviera, Amanda Martins [UNESP] Brunetti, Iguatemy Lourenço [UNESP] |
description |
This study measures the curcumin concentration in rat plasma by liquid chromatography and investigates the changes in the glucose tolerance and insulin sensitivity of streptozotocin-diabetic rats treated with curcumin-enriched yoghurt. The analytical method for curcumin detection was linear from 10 to 500 ng/mL. The C-max and the time to reach C-max (t(max)) of curcumin in plasma were 3.14 perpendicular to 0.9 mu g/mL and 5 minutes (10 mg/kg, i.v.) and 0.06 perpendicular to 0.01 mu g/mL and 14 minutes (500 mg/kg, p.o.). The elimination half-time was 8.64 +/- 2.31 (i.v.) and 32.70 +/- 12.92 (p.o.) minutes. The oral bioavailability was about 0.47%. Changes in the glucose tolerance and insulin sensitivity were investigated in four groups: normal and diabetic rats treated with yoghurt (NYOG and DYOG, resp.) and treated with 90 mg/kg/day curcumin incorporated in yoghurt (NC90 and DC90, resp.). After 15 days of treatment, the glucose tolerance and the insulin sensitivity were significantly improved in DC90 rats in comparison with DYOG, which can be associated with an increase in the AKT phosphorylation levels and GLUT4 translocation in skeletal muscles. These findings can explain, at least in part, the benefits of curcumin-enriched yoghurt to diabetes and substantiate evidences for the curcumin metabolite(s) as being responsible for the antidiabetic activity. |
publishDate |
2015 |
dc.date.none.fl_str_mv |
2015-10-21T20:55:59Z 2015-10-21T20:55:59Z 2015-01-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://www.hindawi.com/journals/ecam/2015/678218/ Evidence-based Complementary And Alternative Medicine. New York: Hindawi Publishing Corporation, p. 1-13, 2015. 1741-427X http://hdl.handle.net/11449/129364 10.1155/2015/678218 WOS:000355808600001 WOS000355808600001.pdf 1066743423929093 3736475025187750 |
url |
http://www.hindawi.com/journals/ecam/2015/678218/ http://hdl.handle.net/11449/129364 |
identifier_str_mv |
Evidence-based Complementary And Alternative Medicine. New York: Hindawi Publishing Corporation, p. 1-13, 2015. 1741-427X 10.1155/2015/678218 WOS:000355808600001 WOS000355808600001.pdf 1066743423929093 3736475025187750 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Evidence-based Complementary And Alternative Medicine 2.064 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
1-13 application/pdf |
dc.publisher.none.fl_str_mv |
Hindawi Publishing Corporation |
publisher.none.fl_str_mv |
Hindawi Publishing Corporation |
dc.source.none.fl_str_mv |
Web of Science reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
|
_version_ |
1808129566012604416 |